The second part of this learning series will focus on strategies for preventing the development of HIV drug resistance including disease prevention, rapid diagnosis, population monitoring and resistance testing. 

Describe strategies for preventing HIV drug resistance and apply these to clinical practice: Learn about strategies for preventing the development of drug resistance, such as adherence counselling, therapeutic drug monitoring, and drug regimen optimisation.

Select the most appropriate testing strategies for patients: learn about the current state of HIV drug resistance testing and understand the methods used to detect and quantify HIV drug resistance, as well as the limitations and challenges associated with current testing strategies.

Select appropriate therapies based on the specific resistance mutations present in patients and explore new treatment options that may be available in the future. Explore emerging therapies for HIV drug-resistant strains and learn about new therapies that target drug HIV drug-resistant strains.

HIV Drug Resistance - Part 2 

HIV Education Group

HIV and drug resistance

HIV drug resistance, clinical implications and strategies to prevent and manage resistance. 

MedShr Editor

This module aims to inform healthcare practitioners on the mechanisms of HIV drug resistance, factors which contribute to drug resistances and the clinical consequences. This learning module is part of an independent medical education programme funded by Gilead. Gilead employees do not have access to the MedShr platform

HIV Drug Resistance - Part 1 

This learning series has been created to inform health care practitioners about HIV drug resistance, the clinical implications and strategies to prevent and manage resistance. This Learning series has been sponsored by Gilead. Gilead employees do not have access to the MedShr Platform.